Vericel Corp Ord Stock Alpha and Beta Analysis
| VCEL Stock | USD 58.14 0.38 0.66% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Vericel Corp Ord. It also helps investors analyze the systematic and unsystematic risks associated with investing in Vericel Corp over a specified time horizon. Remember, high Vericel Corp's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Vericel Corp's market risk premium analysis include:
Beta 1.8 | Alpha (0.05) | Risk 2.89 | Sharpe Ratio 0.11 | Expected Return 0.31 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Vericel |
Vericel Corp Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Vericel Corp market risk premium is the additional return an investor will receive from holding Vericel Corp long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Vericel Corp. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Vericel Corp's performance over market.| α | -0.05 | β | 1.80 |
Vericel Corp expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Vericel Corp's Buy-and-hold return. Our buy-and-hold chart shows how Vericel Corp performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Vericel Corp Market Price Analysis
Market price analysis indicators help investors to evaluate how Vericel Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vericel Corp shares will generate the highest return on investment. By understating and applying Vericel Corp stock market price indicators, traders can identify Vericel Corp position entry and exit signals to maximize returns.
Vericel Corp Return and Market Media
The median price of Vericel Corp for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 44.75 with a coefficient of variation of 12.21. The daily time series for the period is distributed with a sample standard deviation of 5.74, arithmetic mean of 47.06, and mean deviation of 4.82. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Colangelo Dominick of 17500 shares of Vericel Corp at 3.02 subject to Rule 16b-3 | 09/11/2024 |
2 | Disposition of 5834 shares by Gilman Steven C of Vericel Corp at 45.54 subject to Rule 16b-3 | 09/18/2024 |
3 | Acquisition by Jonathan Siegal of 937 shares of Vericel Corp subject to Rule 16b-3 | 09/30/2024 |
4 | Disposition of 568 shares by Jonathan Siegal of Vericel Corp at 41.9 subject to Rule 16b-3 | 10/01/2024 |
5 | Acquisition by Gilman Steven C of 5833 shares of Vericel Corp at 13.05 subject to Rule 16b-3 | 10/16/2024 |
6 | Vericel Corp Ord earnings beat by 0.03, revenue topped estimates | 11/07/2024 |
7 | Vericel Corp Q3 2024 Earnings Call Highlights Strong Revenue Growth and Strategic FDA ... | 11/08/2024 |
8 | Stocks With Rising Relative Strength Vericel | 11/11/2024 |
9 | Vericel Shows Market Leadership With Jump To 84 RS Rating | 11/12/2024 |
10 | Disposition of 17500 shares by Colangelo Dominick of Vericel Corp at 55.57 subject to Rule 16b-3 | 11/13/2024 |
11 | Acquisition by Sean Flynn of 1474 shares of Vericel Corp at 16.25 subject to Rule 16b-3 | 11/18/2024 |
12 | Brown Capital Management LLC Sells 590,626 Shares of Vericel Co. - MarketBeat | 11/21/2024 |
13 | Acquisition by Zerbe Robert L Md of 2500 shares of Vericel Corp at 13.05 subject to Rule 16b-3 | 11/22/2024 |
14 | Pharmaceutical Executive announces winners of 2024 Pharmaceutical Executive APEX Awards | 11/27/2024 |
About Vericel Corp Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Vericel or other stocks. Alpha measures the amount that position in Vericel Corp Ord has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 5.56 | 3.22 | 2.77 | 1.94 | Days Of Inventory On Hand | 97.37 | 106.91 | 77.12 | 73.26 |
Vericel Corp Upcoming Company Events
As portrayed in its financial statements, the presentation of Vericel Corp's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vericel Corp's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Vericel Corp's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Vericel Corp. Please utilize our Beneish M Score to check the likelihood of Vericel Corp's management manipulating its earnings.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Vericel Corp
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Vericel Corp Backtesting, Vericel Corp Valuation, Vericel Corp Correlation, Vericel Corp Hype Analysis, Vericel Corp Volatility, Vericel Corp History and analyze Vericel Corp Performance. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Vericel Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.